Stay updated on Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Sign up to get notified when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history and removed the older funding-lapse notice and Revision: v3.4.1; this is an administrative update with no effect on the study data.
    Difference
    0.5%
    Check dated 2026-02-11T02:07:29.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Notice about lapse in government funding added; page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-03T23:45:17.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle, green highlights for additions, red highlights for deletions, and visible revision labels (e.g., Revision: v3.4.0) to improve readability of changes.
    Difference
    0.7%
    Check dated 2026-01-28T00:32:06.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.3.4 updated in the page history (replacing v3.3.3).
    Difference
    0.1%
    Check dated 2026-01-14T00:40:46.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry (v3.3.3) was added to the record history for NCT04249362, and the HHS Vulnerability Disclosure link was removed from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T09:12:59.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    New Revision: v3.3.2 appears in the history, replacing v3.3.1; this reflects a site update with no changes to trial data or history content.
    Difference
    0.1%
    Check dated 2025-12-01T16:39:50.000Z thumbnail image

Stay in the know with updates to Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab After Radiation in Stage 3 NSCLC – Clinical Trial page.